| Identification | Back Directory | [Name]
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one | [CAS]
415927-29-6 | [Synonyms]
S-Deoxo-3-Keto-17-Acetoxy Fulvestrant
(7α,17β)-3-oxo-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfanyl]nonyl}estr-4-en-17-yl acetate
Estr-4-en-3-one, 17-(acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-,(7a,17b)-
ESTR-4-EN-3-ONE, 17-(ACETYLOXY)-7-[9-[(4,4,5,5,5-PENTAFLUOROPENTYL)THIO]NONYL]-,(7Α,17Β)-
Estr-4-en-3-one, 17-(acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-, (7α,17β)-
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one | [Molecular Formula]
C34H51F5O3S | [MDL Number]
MFCD31560067 | [MOL File]
415927-29-6.mol | [Molecular Weight]
634.82 |
| Hazard Information | Back Directory | [Uses]
S-Deoxo-3-Keto-17-Acetoxy Fulvestrant is an intermediate in the synthesis of Fulvestrant(F862500) which is a novel steroidal estrogen antagonist reported to lack any partial agonist activity. Antineoplastic (hormonal). |
|
|